AI assistant
Denali Therapeutics Inc. — Director's Dealing 2017
Dec 12, 2017
31637_dirs_2017-12-12_6ded2f1a-69d3-43f0-b12e-6f6cd542a035.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Denali Therapeutics Inc. (DNLI)
CIK: 0001714899
Period of Report: 2017-12-12
Reporting Person: Flagship Ventures Fund V, L.P. (10% Owner)
Reporting Person: AFEYAN NOUBAR (10% Owner)
Reporting Person: Flagship Ventures Fund V General Partner LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-12 | Common Stock | C | 8606249 | — | Acquired | 8918749 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-12 | Series A-1 Preferred Stock | $ | C | 8324999 | Disposed | Common Stock (8324999) | Direct | |
| 2017-12-12 | Series A-2 Preferred Stock | $ | C | 125000 | Disposed | Common Stock (125000) | Direct | |
| 2017-12-12 | Series B-1 Preferred Stock | $ | C | 156250 | Disposed | Common Stock (156250) | Direct |
Footnotes
F1: The Series A-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the
Issuer's initial public offering of Common Stock and had no expiration date.
F2: The Series A-2 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the
Issuer's initial public offering of Common Stock and had no expiration date.
F3: The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the
Issuer's initial public offering of Common Stock and had no expiration date.
F4: Held by Flagship Ventures Fund V, L.P. ("Flagship V"). Flagship Ventures Fund V General Partner LLC ("Flagship V LLC") is the general partner of Flagship V. Noubar B. Afeyan, Ph.D. is the manager of Flagship V LLC. Flagship V LLC and Dr. Afeyan may be deemed to possess voting and investment control over all shares held by Flagship V. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.